Andreas Glenthøj
Andreas Glenthøj
Danish Red Blood Cell Center, Rigshospitalet
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ...
Journal of hematology & oncology 14 (1), 168, 2021
Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses
OE Sørensen, SN Clemmensen, SL Dahl, O Østergaard, NH Heegaard, ...
The Journal of clinical investigation 124 (10), 4539-4548, 2014
Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug
A Glenthoj, BY Glenthoj, T Mackeprang, AK Pagsberg, RP Hemmingsen, ...
Psychiatry Research: Neuroimaging 154 (3), 199-208, 2007
Olfactomedin 4 defines a subset of human neutrophils
SN Clemmensen, CT Bohr, S Rørvig, A Glenthøj, H Mora-Jensen, ...
Journal of leukocyte biology 91 (3), 495-500, 2012
Candida albicans escapes from mouse neutrophils
D Ermert, MJ Niemiec, M Röhm, A Glenthøj, N Borregaard, CF Urban
Journal of leukocyte biology 94 (2), 223-236, 2013
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
L Pagano, J Salmanton-García, F Marchesi, A López-García, S Lamure, ...
Blood, The Journal of the American Society of Hematology 139 (10), 1588-1592, 2022
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ...
Leukemia 35 (12), 3444-3454, 2021
Immune mechanisms in myelodysplastic syndrome
A Glenthøj, AD Ørskov, JW Hansen, SR Hadrup, C O’Connell, K Grønbæk
International journal of molecular sciences 17 (6), 944, 2016
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
L Pagano, J Salmanton-García, F Marchesi, O Blennow, ...
Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022
Mitapivat versus placebo for pyruvate kinase deficiency
H Al-Samkari, F Galactéros, A Glenthøj, JA Rothman, O Andres, RF Grace, ...
New England Journal of Medicine 386 (15), 1432-1442, 2022
miRNA-130a regulates C/EBP-ε expression during granulopoiesis
MT Larsen, M Häger, A Glenthøj, F Asmar, SN Clemmensen, ...
Blood, The Journal of the American Society of Hematology 123 (7), 1079-1089, 2014
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report
O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ...
American journal of hematology 97 (8), E312-E317, 2022
The variable manifestations of disease in pyruvate kinase deficiency and their management
H Al-Samkari, EJ Van Beers, KHM Kuo, W Barcellini, P Bianchi, ...
Haematologica 105 (9), 2229, 2020
Clinical presentation and mortality in hospitalized patients aged 80+ years with COVID-19–a retrospective cohort study
LK Karlsson, LH Jakobsen, L Hollensberg, J Ryg, M Midttun, ...
Archives of gerontology and geriatrics 94, 104335, 2021
No effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancer
EP Cramer, A Glenthøj, M Häger, A Juncker-Jensen, LH Engelholm, ...
PLoS One 7 (6), e39646, 2012
Evans syndrome in adults: an observational multicenter study
B Fattizzo, M Michel, JA Giannotta, DL Hansen, M Arguello, E Sutto, ...
Blood advances 5 (24), 5468-5478, 2021
Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial
C Fuchs Andersen, M Omar, A Glenthøj, D El Fassi, HJ Møller, ...
European Journal of Heart Failure 25 (2), 226-234, 2023
Improved clinical outcome of COVID‐19 in hematologic malignancy patients receiving a fourth dose of anti‐SARS‐CoV‐2 vaccine: an EPICOVIDEHA report
J Salmanton‐García, F Marchesi, A Glenthøj, YM Bilgin, J Van Praet, ...
Hemasphere 6 (11), e789, 2022
SARS‐CoV‐2 infection among patients with haematological disorders: severity and one‐month outcome in 66 Danish patients in a nationwide cohort study
A Glenthøj, LH Jakobsen, H Sengeløv, SA Ahmad, K Qvist, A Rewes, ...
European journal of haematology 106 (1), 72-81, 2021
Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial
A Glenthøj, EJ van Beers, H Al-Samkari, V Viprakasit, KHM Kuo, ...
The Lancet Haematology 9 (10), e724-e732, 2022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20